Printer Friendly

SUPRA MEDICAL RELEASES RESULTS FOR FISCAL YEAR 1993

 CHADDS FORD, Pa., June 30 /PRNewswire/ -- Supra Medical Corp. (AMEX: SUM.EC) today reported fiscal year-end March 31, 1993, revenues of $753,957 and a net loss of $2,745,552 or $.12 per share compared to revenues of $530,283 and a net loss of $954,437 or $.06 per share for the previous year.
 Jack Cantwell, chairman and CEO, observed, "Although our 1993 fiscal year revenues rose 42 percent over 1992, the overall expense level rose significantly and resulted in a larger net loss. During the year, we invested heavily in the future. Research and development costs rose 223 percent over the previous year. Our bottom line was also affected negatively by a large increase in depreciation and amortization expense, primarily attributable to the costs associated with the company's Supra Scanners and their related technology."
 The company also reported net revenues of $110,877 and a net loss of $1,023,747 or $.04 per share for the fourth quarter ended March 31, 1993. This compares to revenues of $122,747 and a net loss of $675,319 or $.03 per share for the same period in 1992. Previously, the company recorded net revenues of $51,024 and a net loss of $624,834 or $.03 per share for the third fiscal quarter ending Dec. 31, 1992. This compares to revenues of $136,602 and a net loss of $326,238 or $.02 per share for the same period in 1991.
 Cantwell also commented, "We are beginning to see the fruits of our R&D efforts, and we look forward to solid sales progress in the 1994 fiscal year."
 Supra Medical Corp. develops and markets proprietary medical products which are used in the diagnosis, monitoring and ongoing treatment of skin disorders including skin cancers, burns and various wounds. Additionally, the company is researching the application of its ultrasound technology to the non-invasive diagnosis of breast disorders.
 For more information, contact George Stasen, COO/EVP, at 800-388-6769.
 /delval/
 -0- 6/30/93
 /CONTACT: George Stasen, COO/EVP of Supra Medical, 800-388-6769/
 (SUM)


CO: Supra Medical Corp. ST: Pennsylvania IN: HEA SU: ERN

MP-MK -- PH020 -- 7223 06/30/93 13:58 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 30, 1993
Words:362
Previous Article:INDUSTRIAL SCIENTIFIC CORPORATION ANNOUNCES COMPLETION OF INITIAL PUBLIC OFFERING
Next Article:HARVEY HINMAN ELECTED A CHEVRON VICE PRESIDENT; CHARLES RENFREW TO RETIRE AT END OF OCTOBER
Topics:


Related Articles
SUPRA MEDICAL CORP. RELEASES SECOND QUARTER RESULTS
DIAGNOSTEK, INC. REPORTS FISCAL 1993 RESULTS
SUPRA MEDICAL CORP. RELEASES FIRST QUARTER RESULTS
SUPRA MEDICAL RELEASES SECOND QUARTER RESULTS
/C O R R E C T I O N -- SUPRA MEDICAL/
LIDAK PHARMACEUTICALS REPORTS YEAR-END FINANCIAL RESULTS AND CLINICAL TRIAL UPDATE
SUPRA MEDICAL CORP. RELEASES THIRD QUARTER RESULTS
MERGER PLANNED FOR SUPRA MEDICAL CORP.
PHARMACY MANAGEMENT SERVICES, INC. REPORTS RECORD RESULTS FOR FISCAL YEAR 1994
Chesapeake Biological Laboratories, Inc. Reports Results of Operations For Year Ended March 31, 1999.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters